Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sutezolid EBA study in pulmonary tuberculosis
NCT01225640Phase 2Completed
- Sponsor
- Sequella, Inc.
- Start
- Aug 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sutezolid in pulmonary tuberculosis (TB), sponsored by Sequella, Inc.. Started Aug 2011; status: completed.
02
Drugs
sutezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT01225640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225640.